H.B. Fuller Board Rejects Ancora's $1.2–$1.4B BAS Offer, Launches Market Check to Deleverage

H.B. Fuller (FUL) rejected Ancora's second bid for its Building Adhesive Solutions unit, valuing it at $1.2B-$1.4B. The board deemed the offer insufficient, lacking details, and not capturing the unit's full value. The company will conduct a market check for select segments by year-end 2026 to maximize shareholder value and use proceeds for deleveraging.

H.B. Fuller's board rejected Ancora's revised $1.2B-$1.4B bid for its adhesives business, calling it undervalued. The company's shares are mentioned.

FULLER H B CO (FUL) filed an SEC Form 8-K — Other Events. Exhibit 99.1 H.B. Fuller Board Unanimously Rejects Second Unsolicited, Non-Binding Proposal for Building Adhesive Solutions Segment Announces market check for select market segments ST. PAUL, Minn.--(BUSINESS WIRE)-- H.B. Fuller Company (“H.B. Fuller” or “the Company”) (NYSE: FUL

H.B. Fuller (NYSE:FUL) rejected Ancora's $1.2B-$1.4B offer for its Building Adhesive Solutions unit, citing inadequate valuation and lack of details. The company plans a market check for select asset sales by year-end 2026, with proceeds earmarked for debt reduction. FUL reported 2025 revenue of $3.5B.

H.B. Fuller (FUL) rejected a $1.2B–$1.4B bid for its Building Adhesive Solutions unit from Ancora and plans to explore market interest in other segments. The company views BAS as strategically important and will use any proceeds for debt reduction.

H.B. Fuller (FUL) proposed a cash acquisition of Advanced Medical Solutions (AMS) via a scheme of arrangement, with terms to be disclosed June 25, 2026. FUL insiders bought over $600K of stock in late September, near its 52-week low. The company yields ~2% and has a payout ratio under 30%.